))
Philips has a serious BrightView recall; FDA expands approval for Boston Scientific SCS
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 11, 2024 03:40 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 399692369 series 3481361
Контент предоставлен Fast Five by MassDevice. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Fast Five by MassDevice или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 7, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. GE HealthCare posted fourth-quarter results this week that beat estimates on Wall Street. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the financial highlights. A former Tandem chief commercial officer joined Ascensia as president of CGM. Hear who is taking over in this new role and what their responsibilities will be. Dexcom has launched its new ONE+ CGM system in Europe. Whooley explains what the new system is and how it uses some of the company's other technology. The FDA expanded its approval for Boston Scientific's spinal cord stimulation to include chronic back pain without prior back surgery. Learn more about the system and the data that supported the expanded indication. Philips has a serious BrightView recall due to a potential falling component. The Fast Five hosts talk about the reason behind the recall and if there have been any complaints stemming from the recall. BONUS: Read more from Whooley about Boston Scientific's plan after Farapulse won FDA approval, as well as how catheter design was the key to developing the Farapulse technology.
…
continue reading
161 эпизодов
Поделиться
